Real-world population-based studies showed a high incidence of nocturnal hypoglycemia, with reported rates of 2.6–11.3 events per patient-year in insulin-treated subjects with type 1 diabetes (T1D) [1]. This evidence concerns the gene INS and type 1 diabetes mellitus.